MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.470
-0.110 (-6.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.480
+0.010 (0.68%)
After-hours: Dec 5, 2025, 7:37 PM EST
MaxCyte Employees
MaxCyte had 114 employees as of December 31, 2024. The number of employees decreased by 29 or -20.28% compared to the previous year.
Employees
114
Change (1Y)
-29
Growth (1Y)
-20.28%
Revenue / Employee
$301,921
Profits / Employee
-$400,272
Market Cap
156.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114 | -29 | -20.28% |
| Dec 31, 2023 | 143 | 18 | 14.40% |
| Dec 31, 2022 | 125 | 41 | 48.81% |
| Dec 31, 2021 | 84 | 19 | 29.23% |
| Dec 31, 2019 | 65 | 33 | 103.13% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MXCT News
- 5 days ago - Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO - Business Wire
- 24 days ago - MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - MaxCyte Announces Planned CFO Transition in 2026 - GlobeNewsWire
- 24 days ago - MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance - GlobeNewsWire
- 4 weeks ago - MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance - GlobeNewsWire
- 2 months ago - MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 2 months ago - MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors - GlobeNewsWire
- 2 months ago - MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability - GlobeNewsWire